Frequently Asked Questions
The market is segmented based on North America Artificial Intelligence (AI) in Drug Discovery Market, By Application (Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation and Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug and Others), Technology (Machine Learning, Deep Learning, Natural Language Processing and Others), Drug Type (Small Molecule and Large Molecule), Offering (Software and Services), Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases and Others), End Use (Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Research Centers and Academic Institutes and Others) – Industry Trends and Forecast to 2031.
.
The North America Artificial Intelligence Ai In Drug Discovery Market size was valued at USD 1.07 USD Billion in 2023.
The North America Artificial Intelligence Ai In Drug Discovery Market is projected to grow at a CAGR of 54.9% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico.
